Mayu Shiomi

Hori, 5458585, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Preclinical Rheumatoid Arthritis: Pathogenesis, Risk Stratification, and Therapeutic Interception.

Preclinical Rheumatoid Arthritis: Pathogenesis, Risk Stratification, and Therapeutic Interception.

Journal: Journal of clinical medicine

Published: April 06, 2026

Long-term outcomes remain unchanged despite reduced glucocorticoid exposure in ANCA-associated vasculitis: the multicentre REVEAL cohort study.

Long-term outcomes remain unchanged despite reduced glucocorticoid exposure in ANCA-associated vasculitis: the multicentre REVEAL cohort study.

Journal: Frontiers in immunology

Published: February 09, 2026

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Current Therapeutic Strategies and Future Prospects.

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Current Therapeutic Strategies and Future Prospects.

Journal: Biomolecules

Published: December 12, 2025

Renal outcomes in ANCA-associated vasculitis without clinically apparent kidney involvement: a multicentre REVEAL cohort study.

Renal outcomes in ANCA-associated vasculitis without clinically apparent kidney involvement: a multicentre REVEAL cohort study.

Journal: Rheumatology (Oxford, England)

Published: November 17, 2025

Rituximab versus intravenous cyclophosphamide for anti-neutrophil cytoplasmic antibody-associated vasculitis with severe renal impairment: A multicentre REVEAL cohort study.

Rituximab versus intravenous cyclophosphamide for anti-neutrophil cytoplasmic antibody-associated vasculitis with severe renal impairment: A multicentre REVEAL cohort study.

Journal: Modern rheumatology

Published: October 17, 2025

The Type I Interferon Axis in Systemic Autoimmune Diseases: From Molecular Pathways to Targeted Therapy.

The Type I Interferon Axis in Systemic Autoimmune Diseases: From Molecular Pathways to Targeted Therapy.

Journal: Biomolecules

Published: September 30, 2025

Long-term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA-associated vasculitis in multicenter REVEAL cohort study.

Long-term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA-associated vasculitis in multicenter REVEAL cohort study.

Journal: Journal of internal medicine

Published: September 22, 2025

Updated treatment approaches for eosinophilic granulomatosis with polyangiitis: A systematic scoping review.

Updated treatment approaches for eosinophilic granulomatosis with polyangiitis: A systematic scoping review.

Journal: Modern rheumatology

Published: September 12, 2025

Updated treatment approaches for eosinophilic granulomatosis with polyangiitis: A systematic scoping review.

Updated treatment approaches for eosinophilic granulomatosis with polyangiitis: A systematic scoping review.

Journal: Modern rheumatology

Published: September 12, 2025

Uncovering the New Biology of Giant Cell Arteritis to Guide Therapeutic Strategies.

Uncovering the New Biology of Giant Cell Arteritis to Guide Therapeutic Strategies.

Journal: Journal of clinical medicine

Published: July 29, 2025

Prognostic factors of lenvatinib plus pembrolizumab therapy for advanced or recurrent endometrial cancer: analysis of a multicenter cohort study in Japan.

Prognostic factors of lenvatinib plus pembrolizumab therapy for advanced or recurrent endometrial cancer: analysis of a multicenter cohort study in Japan.

Journal: International journal of clinical oncology

Published: June 04, 2025

Safety of glucocorticoid dose reduction in microscopic polyangiitis: a multicentre REVEAL cohort study.

Safety of glucocorticoid dose reduction in microscopic polyangiitis: a multicentre REVEAL cohort study.

Journal: Modern rheumatology

Published: April 11, 2025

Showing 1-12 of 35

Last Updated: 09/26/2026